Vitamin mixtures

Details for Australian Patent Application No. 2006224771 (hide)

Owner Novartis AG

Inventors Levert, Veronique

Agent Davies Collison Cave

Pub. Number AU-A-2006224771

PCT Pub. Number WO2006/097267

Priority 0502582 16.03.05 FR

Filing date 14 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/375 (2006.01) - Ascorbic acid, i.e. vitamin C

A61K 31/047 (2006.01)

A61K 31/202 (2006.01)

A61K 31/355 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 33/30 (2006.01) Medicinal preparations containing inorganic active ingredients - Zinc

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097267 Priority application(s): WO2006/097267

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224774-Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors

2006224766-Semi-synthetic taxane derivatives with antitumor activity